- Jerini was founded in 1994 as a spin-off from the Medical Faculty (Charité) Humboldt University Berlin to commercialize the SPOT™ technology. The evolving SPOT™ platform was marketed as fee for service projects to pharmaceutical and biotech companies (1995 to 1999). The revenues generated supported the expansion of the company and its technology development. At this stage no venture capital was raised. Due to the expanding applications of its technology platform in drug discovery and proteomics Jerini began its transformation into a drug discovery company. - To support and accelerate the drug discovery transition Jerini raised Euro 4.6 million in January 2000 in a first financing round that included local investors IBB-Bet. GmbH, bmp AG and tbg. In 2001 the company converted to an AG (joint-stock company) and closed its second, private financing round raising Euro 20 million in November 2001. The investors in this round included an international group represented by TVM, 3i, Polytechnos and Sanders Morris and Harris. - In 2000 Jerini started creating the medicinal chemistry platform PepMed™ focusing on the identification of peptide lead structures addressing difficult protein targets and their subsequent systematic transformation into drug-like molecules. - In December 2001 Jerini started its first clinical trials with Icatibant, a peptidomimetic bradykinin receptor antagonist for the indication defined as end-stage liver cirrhosis.
Lombardi Software, Inc. is a provider of business process management (BPM) software and services based in Austin, Texas. Founded in 1999, the company offers a range of products including Teamworks 6, a BPM software suite designed to support process improvement applications, and Blueprint, a software-as-a-service solution that helps organizations map business processes, identify issues, and prioritize improvements. Additionally, Lombardi Software provides process documentation and workflow diagramming tools, as well as a variety of services such as process definition, deployment, on-demand assistance, and education. Their offerings also extend to on-site services, including process design, project management, and service-oriented architecture integration reviews. The company's clientele spans various sectors, including financial services, government, healthcare, insurance, life sciences, manufacturing, retail, and telecommunications.
Lombardi Software, Inc. is a provider of business process management (BPM) software and services based in Austin, Texas. Founded in 1999, the company offers a range of products including Teamworks 6, a BPM software suite designed to support process improvement applications, and Blueprint, a software-as-a-service solution that helps organizations map business processes, identify issues, and prioritize improvements. Additionally, Lombardi Software provides process documentation and workflow diagramming tools, as well as a variety of services such as process definition, deployment, on-demand assistance, and education. Their offerings also extend to on-site services, including process design, project management, and service-oriented architecture integration reviews. The company's clientele spans various sectors, including financial services, government, healthcare, insurance, life sciences, manufacturing, retail, and telecommunications.
IndX Software is an enterprise software company that designs and markets operations intelligence solutions for Fortune 2000 businesses (i.e., primarily process manufacturing) and their supply chains. The company’s product, XHQ, provides a single, coherent view of information that users need for real-time decision support or performance management, by extracting and integrating data from multiple, disparate back-end systems, aggregating and managing content, and distributing information to users. In 1999, Marwit led a $10 million equity investment in the Company.
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
Wayport operates WiFi hotpots for partners since 1998 with key investors Seven Rosen Funds, New Enterprise Associates, Millennium Technology Ventures and Scale Venture Partners.
Valera is a specialty pharmaceutical company concentrating on the development, acquisition and commercialization of products for the treatment of urological and endocrine conditions, diseases and disorders, including products that utilize our proprietary technology.
- Jerini was founded in 1994 as a spin-off from the Medical Faculty (Charité) Humboldt University Berlin to commercialize the SPOT™ technology. The evolving SPOT™ platform was marketed as fee for service projects to pharmaceutical and biotech companies (1995 to 1999). The revenues generated supported the expansion of the company and its technology development. At this stage no venture capital was raised. Due to the expanding applications of its technology platform in drug discovery and proteomics Jerini began its transformation into a drug discovery company. - To support and accelerate the drug discovery transition Jerini raised Euro 4.6 million in January 2000 in a first financing round that included local investors IBB-Bet. GmbH, bmp AG and tbg. In 2001 the company converted to an AG (joint-stock company) and closed its second, private financing round raising Euro 20 million in November 2001. The investors in this round included an international group represented by TVM, 3i, Polytechnos and Sanders Morris and Harris. - In 2000 Jerini started creating the medicinal chemistry platform PepMed™ focusing on the identification of peptide lead structures addressing difficult protein targets and their subsequent systematic transformation into drug-like molecules. - In December 2001 Jerini started its first clinical trials with Icatibant, a peptidomimetic bradykinin receptor antagonist for the indication defined as end-stage liver cirrhosis.
IndX Software is an enterprise software company that designs and markets operations intelligence solutions for Fortune 2000 businesses (i.e., primarily process manufacturing) and their supply chains. The company’s product, XHQ, provides a single, coherent view of information that users need for real-time decision support or performance management, by extracting and integrating data from multiple, disparate back-end systems, aggregating and managing content, and distributing information to users. In 1999, Marwit led a $10 million equity investment in the Company.
Nuforia is an Internet professional services company resulting from the 1999 merger of communications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.